| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3283300 | Clinical Gastroenterology and Hepatology | 2012 | 14 Pages |
Abstract
Biopsy has a low level of diagnostic performance for fibrosis stages F2 and F1. The recommendation for biopsy analysis, instead of a validated biomarker panel such as FibroTest, for the diagnosis of intermediate stages of fibrosis is therefore misleading.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Thierry Poynard, Gilles Lenaour, Jean Christophe Vaillant, Frederique Capron, Mona Munteanu, Daniel Eyraud, Yen Ngo, Helmi M'Kada, Vlad Ratziu, Laurent Hannoun, Frederic Charlotte,